Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Lantern Pharma Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 24 | 22 | −2 |
| Shares | 1.40M | 1.35M | −56.8K (−4.0%) |
| Value | $25.5M | $19.7M | −$5.80M (−22.8%) |
New holders (3)
Institutions that held Lantern Pharma Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| GWM Advisors LLC | 151,316 | $2.21M | 0.06% |
| Steward Partners Investment Advisory, LLC | 250 | $4.00K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held Lantern Pharma Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Flagship Harbor Advisors, LLC | 147,671 | $2.68M |
| Millennium Management LLC | 42,106 | $764.0K |
| Citadel Advisors LLC | 11,192 | $203.0K |
| International Assets Investment Management, LLC | 900 | $17.0K |
| Mesirow Financial Investment Management, Inc. | 818 | $15.0K |